Information:
Fel:
ID
13137
Beskrivning
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00271063
Länk
https://clinicaltrials.gov/show/NCT00271063
Nyckelord
Versioner (1)
- 2016-01-19 2016-01-19 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
19 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Lymphocytic Leukemia NCT00271063
Eligibility Acute Lymphocytic Leukemia NCT00271063
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphocytic Leukemia NCT00271063
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ALL
Item
diagnosis of refractory or relapsed all (acute lymphocytic leukemia)
boolean
C0023449 (UMLS CUI [1])
age
Item
age greater than or equal to 15 years
boolean
C0001779 (UMLS CUI [1])
chemotherapy, radiation, or major surgery
Item
no chemotherapy, radiation, or major surgery within 2 weeks prior to first dose of study drug and recovered from toxic side effects of that therapy, unless treatment is indicated due to progressive disease.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
investigational drugs
Item
no investigational therapy within 4 weeks of first dose of study drug
boolean
C0013230 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status (ps) 0 to 2.
boolean
C1520224 (UMLS CUI [1])
liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
concommitant therapy that includes other chemotherapy
Item
concommitant therapy that includes other chemotherapy that is or may be active against all (except central nervous system [cns] therapy)
boolean
C0392920 (UMLS CUI [1])
condition limiting study protocol
Item
any condition which in the opinion of the investigator, places the subject at unacceptable risk if he/she were to participate in the study.
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
cardiac ejection fraction
Item
cardiac ejection fraction less than 40%
boolean
C0232174 (UMLS CUI [1])
comorbidity
Item
clinically relevant serious co-morbid medical conditions.
boolean
C0009488 (UMLS CUI [1])
pregnant, lactating or not using adequate contraception
Item
pregnant, lactating or not using adequate contraception.
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0032961 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
allergy to doxorubicin or anthracyclines
Item
known allergy to doxorubicin or anthracyclines.
boolean
C0020517 (UMLS CUI [1,1])
C0013089 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])
C0013089 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])